Phyllis C Tien Selected Research

Phyllis C Tien Research Topics

Disease

41	HIV Infections (HIV Infection) 04/2024 - 05/2006
21	Infections 01/2022 - 01/2002
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 05/2006
15	Inflammation (Inflammations) 04/2024 - 01/2011
14	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 12/2009
11	Coinfection 01/2023 - 01/2014
10	Fibrosis (Cirrhosis) 05/2024 - 03/2012
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 04/2015
10	Atherosclerosis 05/2022 - 08/2012
9	Substance-Related Disorders (Drug Abuse) 11/2022 - 04/2008
8	Insulin Resistance 01/2022 - 05/2006
7	Diabetes Mellitus 01/2024 - 01/2002
7	Viremia 02/2023 - 05/2007
5	Hypertension (High Blood Pressure) 01/2023 - 11/2007
5	Hepatitis C 01/2023 - 10/2010
4	COVID-19 03/2024 - 01/2022
4	Liver Diseases (Liver Disease) 10/2017 - 01/2006
4	Chronic Renal Insufficiency 06/2015 - 10/2010
3	Fatty Liver 05/2024 - 01/2002
3	Cognitive Dysfunction 03/2024 - 05/2012
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 10/2007
3	Obesity 01/2015 - 01/2002
3	Albuminuria 10/2014 - 11/2010
3	Hepatitis B 05/2007 - 01/2002
2	Premature Aging 04/2024 - 08/2023
2	Virus Diseases (Viral Diseases) 08/2023 - 01/2018
2	Alcoholism (Alcohol Abuse) 01/2023 - 10/2021
2	Frailty 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2023 - 10/2022
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Chronic Hepatitis C 01/2018 - 01/2016
2	Metabolic Bone Diseases (Osteopenia) 12/2016 - 11/2010
2	Overweight 01/2015 - 01/2014
2	Lipodystrophy 10/2014 - 07/2011
2	Proteinuria 06/2014 - 01/2011
2	Carotid Artery Diseases 05/2014 - 08/2008
2	Kidney Diseases (Kidney Disease) 09/2013 - 11/2010
2	Heart Failure 05/2013 - 06/2009
2	Vitamin D Deficiency 07/2011 - 02/2010
1	Alzheimer Disease (Alzheimer's Disease) 03/2024
1	Post-Acute COVID-19 Syndrome 03/2024

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2008
18	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2007
10	LipidsIBA 03/2023 - 05/2006
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2024 - 03/2012
8	Lipopolysaccharide ReceptorsIBA 01/2022 - 05/2014
7	C-Reactive ProteinIBA 01/2022 - 06/2009
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2009
5	Triglycerides (Triacylglycerol)IBA 02/2024 - 05/2008
5	CreatinineIBA 01/2017 - 11/2010
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2011
4	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 05/2007
4	Protease Inhibitors (Protease Inhibitor)IBA 12/2015 - 05/2007
4	HDL LipoproteinsIBA 01/2014 - 12/2009
3	VaccinesIBA 01/2023 - 11/2004
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
3	cyclo(Arg-Pro) (CI 4)IBA 01/2023 - 12/2013
3	Fatty Acid-Binding ProteinsIBA 01/2022 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 10/2014
3	InterleukinsIBA 01/2020 - 01/2011
3	CytokinesIBA 01/2019 - 02/2016
3	AlbuminsIBA 01/2017 - 11/2010
3	Serum AlbuminIBA 01/2017 - 05/2013
3	fibrin fragment D (D-dimer)IBA 11/2014 - 08/2012
3	Vitamin D FDA LinkGeneric 05/2014 - 07/2011
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014 - 12/2009
3	Lipoproteins (Lipoprotein)IBA 01/2014 - 05/2007
3	oxidized low density lipoproteinIBA 01/2014 - 05/2008
2	Polysaccharides (Glycans)IBA 04/2024 - 08/2023
2	Hormones (Hormone)IBA 01/2024 - 01/2023
2	2019-nCoV Vaccine mRNA-1273IBA 01/2023 - 10/2022
2	BNT162 VaccineIBA 01/2023 - 10/2022
2	Apolipoproteins B (ApoB)IBA 05/2022 - 11/2018
2	EpitopesIBA 05/2022 - 11/2018
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2019
2	Heroin (Diamorphine)IBA 01/2019 - 04/2008
2	AmphetaminesIBA 01/2019 - 04/2008
2	Peptides (Polypeptides)IBA 11/2018 - 03/2016
2	AntigensIBA 11/2018 - 11/2014
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 01/2017 - 01/2014
2	Surface Antigens (Surface Antigen)IBA 10/2016 - 09/2007
2	Plasminogen Activator Inhibitor 1IBA 11/2014 - 03/2013
2	Factor VIII (Coagulation Factor VIII)IBA 11/2014 - 03/2013
2	Tenofovir (Viread)FDA Link 06/2014 - 05/2013
2	Cystatin CIBA 09/2013 - 11/2010
2	Fibrinogen (Factor I)FDA Link 01/2011 - 06/2009
2	Opiate AlkaloidsIBA 06/2010 - 02/2010
2	Illicit Drugs (Recreational Drugs)IBA 04/2008 - 11/2004
2	Hepatitis B Core AntigensIBA 09/2007 - 11/2004
2	AntibodiesIBA 09/2007 - 11/2004
1	Immunoglobulin G (IgG)IBA 04/2024

Therapy/Procedure

26	Therapeutics 01/2023 - 01/2006
21	Highly Active Antiretroviral Therapy (HAART) 02/2016 - 05/2007
17	Art Therapy 04/2024 - 11/2010
4	Polypharmacy 01/2023 - 11/2019
2	Continuity of Patient Care 11/2022 - 01/2020
2	Hormonal Contraception 12/2009 - 07/2008